Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation

Ewing sarcoma is the second most common solid bone malignancy diagnosed in pediatric and young adolescent populations. Despite global co-operative efforts, outcomes for patients with relapsed and refractory disease remains obstinately poor. It has become increasingly clear that disruption of the epi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pishas, Kathleen I., Lessnick, Stephen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284858/
https://www.ncbi.nlm.nih.gov/pubmed/30559927
http://dx.doi.org/10.18632/oncotarget.26326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284858/
https://www.ncbi.nlm.nih.gov/pubmed/30559927
http://dx.doi.org/10.18632/oncotarget.26326

Ejemplares similares